Mitra opens U.S. branch to focus on cardiology nicheCanadian PACS software developer Mitra Imaging has launched a U.S. company to develop cardiology image and information management products. The new company, based in Hartland, WI, will promote
Canadian PACS software developer Mitra Imaging has launched a U.S. company to develop cardiology image and information management products. The new company, based in Hartland, WI, will promote and adapt Mitra's PACS Broker connectivity product for cardiology environments.
Waterloo, Ontario-based Mitra chose to base the U.S. company in Hartland due to its close proximity to area universities as well as several cardiology vendors, such as Camtronics Medical Systems, GE Medical Systems, and Marquette Medical Systems.
The U.S. company will join another Mitra subsidiary, Mitra ApS of Copenhagen, Denmark, which was launched in July.
Mitra also has received Food and Drug Administration 510(k) clearance for Image Vault, a Windows NT-based archiving software offering. Targeted primarily at cardiology, the DICOM-compliant Image Vault stores images on standard magnetic tapes, and has the ability to send, receive, display, store, and archive DICOM non-compressed and JPEG-compressed images. Image Vault, which is scalable, can also read/write a collection of images to and from CD-R media in a method defined by DICOM, according to the firm.
Image Vault is not the first archive offering developed by Mitra. The company developed a Unix-based product for radiology in an exclusive relationship with Agfa. That exclusive agreement applies only to radiology archiving, however, and Mitra anticipates that multiple firms will be accessing Image Vault in the cardiology realm, said Eric Peterson, president.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.